Clinical Trial Update: Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic natural killer cells in patients with recurrent ovarian, Fallopian tube, and primary peritoneal cancers; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-09-15